XML 33 R21.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT AND GEOGRAPHIC INFORMATION
 6 Months Ended
Jun. 30, 2021
Segment Reporting [Abstract]  
SEGMENT AND GEOGRAPHIC INFORMATION SEGMENT AND GEOGRAPHIC INFORMATION
The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.
•The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.
•The Tissue Technologies segment includes such offerings as skin and wound repair, bone grafts, and nerve and tendon repair products. In conjunction with the sale of the Extremity Orthopedics business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021.
The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.
The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three and six months ended June 30, 2021 and 2020 are as follows :
Three Months Ended June 30,Six Months Ended June 30,
Dollars in thousands2021202020212020
Segment Net Sales
Codman Specialty Surgical$256,837 $169,778 $498,078 $401,218 
Tissue Technologies
133,155 88,887 251,985 211,771 
Total revenues$389,992 $258,665 $750,063 $612,989 
Segment Profit
Codman Specialty Surgical$113,996 $65,256 $220,774 $152,491 
Tissue Technologies
64,413 28,688 114,42459,958 
Segment profit178,409 93,944 335,198 212,449 
Amortization(4,198)(8,073)(8,725)(15,050)
Corporate and other(122,357)(71,791)(243,905)(156,216)
Operating income$51,854 $14,080 $82,568 $41,183 
The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.
The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:
 Three Months Ended June 30,Six Months Ended June 30,
Dollars in thousands2021202020212020
United States$278,186 $181,850 $525,979 $428,702 
Europe48,437 32,026 94,256 77,922 
Asia Pacific44,306 33,501 91,601 73,461 
Rest of World19,063 11,288 38,227 32,904 
Total Revenues$389,992 $258,665 $750,063 $612,989